Working… Menu
Trial record 73 of 9085 for:    Genetic Diseases, Inborn AND genetic disorder

Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01529840
Recruitment Status : Completed
First Posted : February 9, 2012
Last Update Posted : January 18, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2005
Actual Study Completion Date : September 2005